The introduction of inhibitors of the cyclic GMP phosphodiesterase (PDE) 5 into clinical urology is mainly the result of the characterization of the physiology of nonvascular and vascular penile ...
The medications studied are PDE5 inhibitors: sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra), all approved for the treatment of ED. In the late 1980s ...
A new study reports that mirodenafil, a newly developed oral phosphodiesterase type 5 (PDE5) inhibitor, is an efficacious and safe treatment for erectile dysfunction (ED). Many men with ED ...
The introduction of phosphodiesterase-5 inhibitors (PDE5Is) in the market, such as generic Levitra, has revolutionized the ...
Although phosphodiesterase 5 (PDE5) inhibitors are a highly effective and easy-to-use treatment for erectile dysfunction (ED), many men discontinue therapy. Inadequate education and follow-up of ...
IIEF was affected by some baseline characteristics including ED severity, pretreatment with PDE5 inhibitors ... sites were selected randomly from a list of investigators who expressed interest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results